NCT07098052View on ClinicalTrials.gov

A Study of HDM2020 in Patients With Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

August 11, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

May 30, 2027

Conditions

Solid Tumor

Interventions

DRUG

HDM2020

FGFR2b-ADC

Trial Locations (1)

510060

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors

lead

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

INDUSTRY